Abstract
P-Glycoprotein (PGP) encoded by the multi-drug-resistance 1 ( MDR1) gene is a member of theATP-binding cassette (ABC) transporter family, drug-transporting proteins involved in the bioavailability and pharmacokinetics of various drugs. Several single nucleotide polymorphisms (SNPs) in the MDR1 gene have been identified so far that may influence PGP expression levels and function. Thus, genotyping for MDR1 polymorphisms and determining specific haplotypes may become an important tool in predicting individual susceptibility to developing drug resistance. We developed a new multiplexed allele-specific PCR method based on the principle of mutagenically separated PCR (MS-PCR) for rapid and reliable simultaneous genoptyping of the C3435T polymorphism in exon 26 of the MDR1 gene and two additional SNPs (G2677T/A in exon 21 and C1236T in exon 12), which are in linkage disequilibrium with MDR1 C3435T. The accuracy and reliability of this method was confirmed by sequencing the respective regions in the MDR1 gene. This newly developed MDR1 MS-PCR will facilitate fast, accurate and economic analysis of MDR1 genotypes and will provide important information in optimizing individual therapeutic approaches.
References
1 Gottesman MM, Pastan I, Ambudkar SV. P-Glycoprotein and multidrug resistance. Curr Opin Genet Dev 1996; 6: 610–7. 10.1016/S0959-437X(96)80091-8Search in Google Scholar
2 Fromm MF. The influence of MDR1 polymorphisms on P-glycoprotein expression and function in humans. Adv Drug Deliv Rev 2002; 54: 1295–310. 10.1016/S0169-409X(02)00064-9Search in Google Scholar
3 Ambudkar SV, Dey S, Hrycyna CA, Ramachandra M, Pastan I, Gottesmann MM. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol 1999; 39: 361–98. 10.1146/annurev.pharmtox.39.1.361Search in Google Scholar PubMed
4 Hoffmeyer S, Burk O, von Richter O, Arnold HP, Brockmoller J, Johne A, et al. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA 2000; 97: 3473–8. 10.1073/pnas.97.7.3473Search in Google Scholar PubMed PubMed Central
5 Tanabe M, Ieiri I, Nagata N, Inoue K, Ito S, Kanamori Y, et al. Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene. J Pharmacol Exp Ther 2001; 297: 1137–43. Search in Google Scholar
6 Illmer T, Schuler US, Thiede C, Schwarz UI, Kim RB,Gotthard S, et al. MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients. Cancer Res 2002; 62: 4955–62. Search in Google Scholar
7 Rust S, Funke H, Assmann G. Mutagenically separated PCR (MS-PCR): a highly specific one-step procedure for easy mutation detection. Nucleic Acids Res 1993; 21: 3623–9. 10.1093/nar/21.16.3623Search in Google Scholar PubMed PubMed Central
8 Endler G, Kyrle PA, Eichinger S, Exner M, Mannhalter C. Multiplexed mutagenically separated PCR: simultaneous single tube detection of the factor V R506Q (G1691A), the prothrombin G20210A, and the methylene tetrahydrofolate reductase A223V (C677T) variants. Clin Chem 2001; 47: 333–5. 10.1093/clinchem/47.2.333Search in Google Scholar
9 Bowen DJ, Standen GR, Granville S, Bowley S, Wood NA, Bidwell J. Genetic diagnosis of factor V Leiden using heteroduplex technology. Thromb Haemost 1997; 77: 119–22. 10.1055/s-0038-1655917Search in Google Scholar
10 Zimprich F, Sunder-Plassmann R, Stogmann E, Dal-Bianco A, Zimprich A, Plumer S, et al. Association of drug-transporter gene ABCB1 haplotypes with pharmacoresistance in temporal lobe epilepsy. Neurology 2004; 63: 1087–9. 10.1212/01.WNL.0000141021.42763.F6Search in Google Scholar PubMed
©2005 by Walter de Gruyter Berlin New York
